Comparative outcomes of percutaneous coronary interventions in diabetics vs non-diabetics with prior coronary artery bypass grafting

European Heart Journal

Volumn 23, Issue 18, 2002, Pages 1456-1464

  Mathew, V ^a   Wilson, S H ^a   Barsness, G W ^a   Frye, R L ^a   Lennon, R ^a   Holmes, D R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Coronary artery bypass grafting; Diabetes; Mortality; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; TICLOPIDINE;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMORBIDITY; CONFIDENCE INTERVALS; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036764796     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.3155     Document Type: Article

References (20)

1. Bypass Angioplasty Revascularization Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation by treatment and diabetic status. J Am Coll Cardiol 2000; 35: 1122-9.
2. Detre KM, Guo P, Holubkov R et al. Coronary revascularization in diabetic patients: A comparison of the randomization and observational components of the Bypass Angioplasty. Revascularization Investigation. Circulation 1999; 99: 633-40.
3. Barsness GW, Peterson ED, Ohman EM et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 1997; 96: 2551-6.
4. Campeau L, Lesperance J, Hermann J, Carbara F, Grondin CM, Bourassa MG. Loss of the improvement of angina between 1 and 7 years after aortocoronary bypass surgery: correlations with changes in vein grafts and in coronary arteries. Circulation 1979; 60: 1-5.
5. Bourassa MG, Enjalbert M, Campeau L. Progression of coronary artery disease between 10 and 12 years after coronary artery bypass graft surgery. In: Roskamm H, ed. Prognosis of Coronary Heart Disease. Berlin: Springer-Verlag, 1983: 150.
6. Frick MH, Valle M, Harjola PT. Progression of coronary artery disease in randomized medical and surgical patients over a 5-year angiographic follow-up. Am J Cardiol 1983; 52: 681-5.
7. Hwang MH, Meadows WR, Palac RT et al. Progression of native coronary artery disease at 10 years: insights from a randomized study of medical versus surgical therapy for angina. J Am Coll Cardiol 1990; 16: 1066-70.
8. Pick AW, Mullany CJ, Orszulak TA, Daly RC, Schaff HV. Third and fourth operations for myocardial ischemia: short-term results and long-term survival. Circulation 1997; 96: 26-31.
9. Hannan EL, Kilburn H, O'Donnell JF, Lukacik G, Shields EP. Adult open-heart surgery in New York state. An analysis of risk factors and hospital mortality rates. JAMA 1990; 264: 2768-74.
10. Loop FD, Lytle BW, Cosgrove DM et al. Reoperation for coronary atherosclerosis. Changing practice in 2,509 consecutive patients. Annals Surg 1990; 212: 378-86.
11. Lytle BW, Loop FD, Cosgrove DM. Fifteen hundred coronary reoperations: results and determinants of early and late survival. J Thoracic Cardiovasc Surg 1987; 93: 847-59.
12. Lytle BW, Loop FD, Taylor PC et al. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries. J Thoracic Cardiovasc Surg 1993; 105: 605-14.
13. Mathew V, Clavell AL, Lennon RJ, Grill DE, Holmes DR, Jr. Percutaneous coronary interventions in patients with prior coronary artery bypass surgery: Changes in patient characteristics and outcome during two decades. Am J Med 2000; 108: 127-35.
14. Van Belle E, Ketelers R, Bauters C et al. Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up. Circulation 2001; 103: 1218-24.
15. Van Belle E, Bauters C, Hubert E et al. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 1997; 96: 1454-60.
16. Rozenman Y, Sapoznikov D, Mosseri M et al. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. J Am Coll Cardiol 1997; 30: 1420-5.
17. Mathew V, Berger PB, Lennon RJ, Gersh BJ, Holmes DR, Jr. Comparison of percutaneous interventions for unstable angina pectoris in patients with and without prior coronary artery bypass grafting. Am J Cardiol 2000; 86: 931-7.
18. Stephan WJ, O'Keefe JH, Piehler JM et al. Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery. J Am Coll Cardiol 1996; 28: 1140-6.
19. Ernst SM, van der Feltz TA, Ascoop CA et al. Percutaneous transluminal coronary angioplasty in patients with prior coronary artery bypass grafting. Long-term results. J Thoracic Cardiovasc Surg 1987; 93: 268-75.
20. Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol 2000; 35: 992-8.